JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that its ThermoStem® program has led to a study to be published in the peer-reviewed journal Stem Cells. The newly identified human adult brown fat stem cells discussed in the study have the potential to lead to the development of a cell-based method for the treatment of type 2 diabetes and obesity.
Help employers find you! Check out all the jobs and post your resume.